Talking Urology Podcast
Talking Urology
Add to My Podcasts
Episodes
About
Reviews
Promote
APCC 2017 Interviews - Chris Sweeney 2
1 minutes
Posted Nov 17, 2017 at 2:02 am.
0:00
1:35
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Chris Sweeney discusses which is best? Abiraterone vs docetaxal with ADT for hormone naïve metastatic prostate cancer
Previous
APCC 2017 Interviews - Chris Sweeney
Next
APCC 2017 Interviews - Peter Black
← See all 115 episodes of Talking Urology Podcast
